←
IFPMA16,232 posts
IFPMA avatar

IFPMA

@IFPMA

We represent the innovative pharmaceutical industry globally, with a focus on three priorities: innovation, equitable access, and ethics. #AlwaysInnovating

◷ Joined November 2012▧ 6,137 Photos and videos
IFPMA avatar
IFPMA@IFPMA·Apr 27

Investing in innovative medicines and vaccines doesn’t just save lives - it transforms our future. It strengthens health, drives economic growth, and improves health security. #AlwaysInnovating

0:53
IFPMA avatar
IFPMA@IFPMA·Nov 4

From patient experiences to foundational scientific data, pharma R&D draws on many types of data. Used responsibly, data can accelerate new medicines and vaccines, and a data ecosystem that supports innovation helps patients benefit sooner. ifpma.org/areas-of-work/fost…

Post attachment
IFPMA avatar
IFPMA@IFPMA·Oct 27

A strong IP system helps turn scientific ideas into health breakthroughs. @DavidReddyIFPMA on what @WIPO’s #GlobalInnovationIndex highlights about innovation ecosystems 👇 ifpma.org/insights/from-pilo…

IFPMA avatar
IFPMA@IFPMA·Oct 26

Vulnerability does not begin at 65. Discover how treating preventive care as an investment can help Europe turn longer lives into stronger economies and set a global example 👇 ifpma.org/insights/longer-he…

Post attachment
IFPMA avatar
IFPMA@IFPMA·Oct 23

#NCDs are both a health and an economic challenge. IFPMA Executive Director, Global Health, Access, and Financing, Derrick Sim, makes the case for treating NCDs as an investment in healthier lives, stronger labor markets, and more resilient economies 👇 linkedin.com/pulse/case-trea…

IFPMA avatar
IFPMA@IFPMA·Sep 29

On #WorldHeartDay, we’re reminded how prevention and innovation help people live healthier lives. CVRM conditions drive nearly half of NCD deaths, yet new diagnostics and treatments are transforming how we manage their interconnected progression. 🔗 ifpma.org/areas-of-work/adva…

Post attachment
IFPMA avatar
IFPMA@IFPMA·Sep 18

Global health #security remains fragile. The #Ebola outbreak underscores the need for sustained investment in pharmaceutical innovation, stronger health systems, & policy and financing frameworks that make scientific progress possible. Learn more 👇 ifpma.org/publications/stren…

Post attachment
IFPMA avatar
IFPMA@IFPMA·Sep 14

Adult #immunization is vital for healthy aging. By 2060, adults 55–64 will be 30% of the workforce. Each $1 invested returns up to 19×, while preventable diseases cost G20 economies $1T yearly. 🔗 Learn more: ifpma.org/publications/adult…